期刊文献+

地塞米松磷酸钠注射液仿制制剂与原研制剂有关物质比较

Comparison of Related Substances Between the Generic and Original-Patented Dexamethasone Sodium Phosphate Injection
下载PDF
导出
摘要 目的建立检测地塞米松磷酸钠注射液中有关物质的高效液相色谱法,比较仿制制剂和原研制剂的质量差异。方法色谱柱为Kromasil C_(8)柱,流动相A为0.1 mol/L乙酸铵溶液(用乙酸调pH至3.8)-甲醇(65∶35,V/V),流动相B为0.1 mol/L乙酸铵溶液(用乙酸调pH至4.0)-甲醇(30∶70,V/V),梯度洗脱,流速为1.0 mL/min,检测波长为254 nm。结果地塞米松磷酸钠与7个已知杂质A-G分离良好,质量浓度在0.596~11.916μg/mL范围内与峰面积线性关系良好(r=0.9994)。变更处方后,不再添加抗氧剂亚硫酸钠,不再检出杂质Ⅰ。仿制制剂中已知杂质、未知杂质的数量和含量均与原研制剂相当。结论该方法操作简单、重复性好、专属性强,可用于地塞米松磷酸钠注射液的杂质检查,保障仿制制剂质量不劣于原研制剂。 Objective To establish a high-performance liquid chromatography(HPLC)method for the determination of related substances in Dexamethasone Sodium Phosphate Injection,and to compare the quality differences between the generic and original-patented preparations.Methods The chromatographic column was Kromasil C_(8) column,the mobile phase A was 0.1 mol/L ammonium acetate solution(adjusted to pH 3.8 with acetic acid)-methanol(65∶35,V/V),the mobile phase B was 0.1 mol/L ammonium acetate solution(adjusted to pH 4.0 with acetic acid)-methanol(30∶70,V/V),the elution method was gradient elution,the flow rate was 1.0 mL/min,and the detection wavelength was 254 nm.Results Dexamethasone sodium phosphate was well separated from seven known substances(impurity A-impurity G),and its linear range was 0.596-11.916μg/mL(r=0.9994).After the prescription was changed with no adding antioxidant sodium sulfite,the impurityⅠin the preparation was not detected.The quantities and contents of known and unknown impurities in the generic preparation were similar to those in the original-patented preparation.Conclusion The method is simple,repeatable and specific,which can be used for the impurity detection of Dexamethasone Sodium Phosphate Injection to ensure that the quality of generic preparation is not inferior to that of the original-patented preparation.
作者 路惬楠 王柳 孙婷 张轶华 LU Qienan;WANG Liu;SUN Ting;ZHANG Yihua(Hebei Institute for Drug and Medical Device Control·NMPA Key Laboratory for Quality Control and Evaluation of Generic Drug,Shijiazhuang,Hebei,China 050200)
出处 《中国药业》 CAS 2022年第23期68-70,共3页 China Pharmaceuticals
基金 中央引导地方科技发展资金项目[216Z2605G]。
关键词 地塞米松磷酸钠注射液 处方变更 仿制制剂 原研制剂 有关物质 Dexamethasone Sodium Phosphate Injection prescription change generic preparation original-patented preparation related substance
  • 相关文献

参考文献8

二级参考文献31

  • 1徐雪梅,夏晓萍.地塞米松磷酸钠注射液的工艺改进[J].医药导报,2005,24(7):621-621. 被引量:1
  • 2阮宝强,杨腊虎.醋酸地塞米松片及其有关物质分析[J].药物分析杂志,2007,27(3):412-413. 被引量:5
  • 3国家药品标准[S].第十一册.149,2002.
  • 4中国药典[S].2010年版.二部.附录ⅨJ.
  • 5ChP(中国药典).2010.VolⅡ(二部):922.
  • 6英国药典[S].2010:A338-A340.
  • 7美国药典[S].34版,4283-4283.
  • 8中国药典临床用药须知[G].化学药和生物制品卷.北京:中国医药科技出版社,2010:603-603.
  • 9Standards of State Food and Drug Administration (国家食品药品监督管理局).Data enquiry:dexamethasone sodium phosphate injection . .http://app1.sfda.gov.cn/datasearch/face3/base.jsp.
  • 10USP35-NF30.2012.S2:2845.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部